Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Raha Pharmaceutical is a prominent pharmaceutical manufacturing company based in Isfahan, Iran, dedicated to the production of a wide array of generic medicinal products and nutritional supplements. Established in 2004, the company operates state-of-the-art facilities that adhere to Good Manufacturing Practice (GMP) standards to ensure the quality and safety of its diverse portfolio. Raha's product line spans multiple therapeutic categories, including cardiovascular, central nervous system, gastrointestinal, and endocrine treatments, available in various formulations such as solid orals, liquids, and semi-solids. The company plays a critical role in the regional healthcare ecosystem by providing affordable access to essential medications and actively engaging in the development of new generic formulations. Through its commitment to research and development, Raha continues to expand its reach into international markets while maintaining a strong domestic presence.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Raha Pharmaceutical.